Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation (with GnRH agonist and rFSH)
- PMID: 17611831
- DOI: 10.1080/00016340701415152
Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation (with GnRH agonist and rFSH)
Abstract
Background: The study was aimed at investigating the effects of ovarian high response during controlled ovarian hyperstimulation (COH) on implantation and pregnancy outcome in fresh IVF/ICSI cycles, and subsequent frozen-thawed embryo transfer (FET) cycles.
Methods: An analysis of 1,196 cycles using a long protocol with GnRHa and rFSH was performed. A serum oestrial level (peak E(2)) was obtained on the day of hCG administration, and patients were grouped by peak E(2) percentile distribution into 3 groups. Normal responder was set as cut-off concentrations between percentile (P)25 and P75 (Group A: 1,199-3,047 pg/ml, 595 cycles). Moderate high responders were classified as peak E(2) between P75-P90 (Group B: 3,048-4,127 pg/ml, 180 cycles). For the high response group, the E(2) cut-off concentration was set as P90 and above (Group C: >or=4,128 pg/ml, 119 cycles). Oocyte/embryo parameters and clinical outcomes were compared among the 3 groups in fresh cycles and subsequent FET cycles.
Results: Comparisons between groups revealed no difference in the quality of oocyte retrieved and in fertilisation rates. Group C showed decreased trends in implantation and pregnancy rates compared with Group A, but statistical significance was reached only for the difference in implantation rates. Implantation and pregnancy rates in FET cycles were similar among the 3 groups.
Conclusions: High serum estrogen levels were detrimental to implantation, but not to the quality of oocytes, which may be due to an adverse effect on endometrial receptivity in COH cycles.
Similar articles
-
Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial.Hum Reprod. 2005 Feb;20(2):390-6. doi: 10.1093/humrep/deh625. Epub 2004 Dec 2. Hum Reprod. 2005. PMID: 15576390 Clinical Trial.
-
Serum estradiol levels during controlled ovarian hyperstimulation influence the pregnancy outcome of in vitro fertilization in a concentration-dependent manner.Fertil Steril. 2010 Feb;93(2):442-6. doi: 10.1016/j.fertnstert.2009.02.066. Epub 2009 Apr 25. Fertil Steril. 2010. PMID: 19394001
-
[Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].Zhonghua Fu Chan Ke Za Zhi. 2006 Jun;41(6):368-71. Zhonghua Fu Chan Ke Za Zhi. 2006. PMID: 16831355 Chinese.
-
The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis.Hum Reprod Update. 2009 Jan-Feb;15(1):5-12. doi: 10.1093/humupd/dmn053. Hum Reprod Update. 2009. PMID: 19091754 Review.
-
What is the 'ideal' duration of progesterone supplementation before the transfer of cryopreserved-thawed embryos in estrogen/progesterone replacement protocols?Hum Reprod. 2005 May;20(5):1127-34. doi: 10.1093/humrep/deh762. Epub 2005 Feb 3. Hum Reprod. 2005. PMID: 15695314 Review.
Cited by
-
Relationship between a low ratio of serum estradiol to follicle number and fertility treatment outcomes: A retrospective cohort study of 516 cases.Medicine (Baltimore). 2018 Aug;97(34):e12017. doi: 10.1097/MD.0000000000012017. Medicine (Baltimore). 2018. PMID: 30142848 Free PMC article.
-
The influence of early cleavage on embryo developmental potential and IVF/ICSI outcome.J Assist Reprod Genet. 2009 Aug;26(8):437-41. doi: 10.1007/s10815-009-9342-6. Epub 2009 Sep 30. J Assist Reprod Genet. 2009. PMID: 19789972 Free PMC article.
-
The Exploration of Poor Ovarian Response-Related Risk Factors: A Potential Role of Growth Differentiation Factor 8 in Predicting Ovarian Response in IVF-ET Patient.Front Endocrinol (Lausanne). 2021 Sep 24;12:708089. doi: 10.3389/fendo.2021.708089. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34630324 Free PMC article.
-
Expression profile analysis of LncRNAs and mRNAs in pre-receptive endometrium of women with polycystic ovary syndrome undergoing in vitro fertilization-embryo transfer.BMC Med Genomics. 2024 Jan 19;17(1):26. doi: 10.1186/s12920-024-01806-w. BMC Med Genomics. 2024. PMID: 38243290 Free PMC article.
-
A unique human chorionic gonadotropin antagonist suppresses ovarian hyperstimulation syndrome in rats.Endocrinology. 2009 Aug;150(8):3807-14. doi: 10.1210/en.2009-0107. Epub 2009 May 14. Endocrinology. 2009. PMID: 19443574 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials